Polyclonal hyperviscosity syndrome
A rare hematologic disease characterized by high serum viscosity due to polyclonal expansion of immunoglobulins most commonly in the context of Waldenström’s macroglobulinemia as well as a variety of disorders of immune dysregulation. Patients present with signs and symptoms involving multiple organs such as bleeding diathesis mucosal bleeding retinal hemorrhage headache stroke pulmonary hypertension and congestive heart failure.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version September 2023.
Newly diagnosed with
Polyclonal hyperviscosity syndrome?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Care-for-Rare America Inc
To establish a global alliance in order to identify the genetic causes of rare diseases and develop effective treatments, following a three-stage approach: recognize, understand, cure.
Youth and Women for Opportunities Uganda-YWOU
Youth and Women for Opportunities-YWOU an organization that we represent is patient organization re-presentative, patient and institution and individual capacity builder supporting PLWRD’s to obtain diagnosis, treatment and drugs for those suffering consequences of being undiagnosed or misdiagnosed and lack treatment and those who lack precise diagnosis for rare, orphan and undiagnosed diseases preventing PLWRD’s accessing the most adapted care, treatment or surgery, have delayed access to the most appropriate care, treatment or surgery
For a list of clinical trials in this disease area, please click here.